doctor-skin-hand-checkup-abcvidFor the first time, patients with the deadliest form of skin cancer have two new treatment options that prolong survival, according to new research presented at a cancer conference in Chicago on Sunday.

One drug specifically targets a mutated gene that tells a cancer cell to grow, the other boosts a patient’s immune system in the fight against the disease. Both drugs cause tumors to shrink and prolong survival for patients with melanoma that has spread to other parts of the body.

(READ the story at CNN)

Thanks to Joel Arellano for submitting the story to our Facebook page!

Leave a Reply